233 related articles for article (PubMed ID: 28454430)
1. WT1-associated protein is a novel prognostic factor in pancreatic ductal adenocarcinoma.
Li BQ; Huang S; Shao QQ; Sun J; Zhou L; You L; Zhang TP; Liao Q; Guo JC; Zhao YP
Oncol Lett; 2017 Apr; 13(4):2531-2538. PubMed ID: 28454430
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of Cell Division Cycle Associated 2 Expression on Pancreatic Ductal Adenocarcinoma.
Wang MY; Niu ZY; Gao XG; Zhou L; Liao Q; Zhao YP
Chin Med Sci J; 2016 Sep; 31(3):149-154. PubMed ID: 27733221
[TBL] [Abstract][Full Text] [Related]
3. Wilms Tumor 1-Associated Protein Expression Is Linked to a T-Cell-Inflamed Phenotype in Pancreatic Cancer.
Xu JL
Dig Dis Sci; 2023 Mar; 68(3):831-840. PubMed ID: 35859262
[TBL] [Abstract][Full Text] [Related]
4. WTAP Expression Predicts Poor Prognosis in Malignant Glioma Patients.
Xi Z; Xue Y; Zheng J; Liu X; Ma J; Liu Y
J Mol Neurosci; 2016 Oct; 60(2):131-6. PubMed ID: 27370540
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of MKK4 and MKK7 in resectable pancreatic ductal adenocarcinoma.
Lu J; Zhou L; Yang G; Liang ZY; Zhou WX; You L; Yuan D; Li BQ; Guo JC; Zhao YP
Hum Pathol; 2019 Apr; 86():143-154. PubMed ID: 30537492
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma.
Yu R; Li C; Lin X; Chen Q; Li J; Song L; Lin L; Liu J; Zhang Y; Kong W; Ouyang X; Chen X
Pathol Res Pract; 2017 Aug; 213(8):964-968. PubMed ID: 28559119
[TBL] [Abstract][Full Text] [Related]
7. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
8. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
9. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
[TBL] [Abstract][Full Text] [Related]
10. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
11. BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis.
Huang Y; Zheng J; Tan T; Song L; Huang S; Zhang Y; Lin L; Liu J; Zheng P; Chen X; Chen X; Ouyang X
Int J Biol Markers; 2018 May; 33(2):189-194. PubMed ID: 29076521
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma.
Zheng J; Huang S; Huang Y; Song L; Yin Y; Kong W; Chen X; Ouyang X
Tumour Biol; 2016 Jun; 37(6):7853-9. PubMed ID: 26695153
[TBL] [Abstract][Full Text] [Related]
13. Identifying the role of Wilms tumor 1 associated protein in cancer prediction using integrative genomic analyses.
Wu LS; Qian JY; Wang M; Yang H
Mol Med Rep; 2016 Sep; 14(3):2823-31. PubMed ID: 27430156
[TBL] [Abstract][Full Text] [Related]
14. Identification of WTAP, a novel Wilms' tumour 1-associating protein.
Little NA; Hastie ND; Davies RC
Hum Mol Genet; 2000 Sep; 9(15):2231-9. PubMed ID: 11001926
[TBL] [Abstract][Full Text] [Related]
15. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma.
Kanai T; Ito Z; Oji Y; Suka M; Nishida S; Takakura K; Kajihara M; Saruta M; Fujioka S; Misawa T; Akiba T; Yanagisawa H; Shimodaira S; Okamoto M; Sugiyama H; Koido S
Oncol Lett; 2018 Aug; 16(2):2682-2692. PubMed ID: 30008944
[TBL] [Abstract][Full Text] [Related]
17. High Expression of P38α and Preoperative Carbohydrate Antigen 19-9 Indicate Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma.
Chen J; Zhao T; Jia S; Zhou S; Zhou L; Wang S; Ding G; Jiang G; Cao L
J Cancer; 2018; 9(4):650-659. PubMed ID: 29556322
[No Abstract] [Full Text] [Related]
18. Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma.
Yao H; Yang Z; Liu Z; Miao X; Yang L; Li D; Zou Q; Yuan Y
Cancer Biomark; 2016; 17(4):397-404. PubMed ID: 27689616
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma.
Ji M; Jin A; Sun J; Cui X; Yang Y; Chen L; Lin Z
Oncol Lett; 2017 May; 13(5):2996-3002. PubMed ID: 28521407
[TBL] [Abstract][Full Text] [Related]
20. Mortalin expression in pancreatic cancer and its clinical and prognostic significance.
Cui X; Li Z; Piao J; Li J; Li L; Lin Z; Jin A
Hum Pathol; 2017 Jun; 64():171-178. PubMed ID: 28412209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
